Search Results 1171-1180 of 18448 for Immunode

  1. A Study to Evaluate AVID200 in Myelofibrosis Patients - Mayo Clinic

    Known history of human immunodeficiency virus (HIV), or known active hepatitis A, B, or C infection. Organ transplant recipients other than bone marrow ...

  2. A Study to Evaluate the Effectiveness and Safety of Pembrolizumab Combined with Bacillus Calmette-Guerin in High-Risk Non-Muscle Invasive Bladder Cancer - Mayo Clinic

    - Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy or any other form of immunosuppressive therapy within 7 days of start ...

  3. A Study to Compare CMP-001 Combined with Nivolumab to Nivolumab Alone in Advanced Melanoma Subjects - Mayo Clinic

    Known history of immunodeficiency. Known additional malignancy that has progressed or required active treatment within the past 3 years. Exceptions include ...

  4. Study of Efficacy and Safety of CTL019 in Adult ALL Patients - Mayo Clinic

    Human Immunodeficiency Virus (HIV) infection at screening;; Presence of grade 2 to 4 acute or extensive chronic graft-versus-host disease (GVHD) at screening ...

  5. Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis - Mayo Clinic

    Human immunodeficiency virus infection;; History of active tuberculosis or positive tuberculosis test without a completed course of appropriate treatment ...

  6. SUPRAME-ACTengine® IMA203 Vs. Investigator's Choice Of Treatment In Previously Treated, Unresectable Or Metastatic Cutaneous Melanoma - Mayo Clinic

    * History of or current immunodeficiency disease or prior treatment compromising immune function at the discretion of the treating physician * History of ...

  7. Breast rash - Mayo Clinic

    Atopic dermatitis, eczema, and noninfectious immunodeficiency disorders. In: Andrews' Diseases of the Skin Clinical Atlas. 2nd ed. Elsevier; 2023. https ...

  8. A Study to Test the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer - Mayo Clinic

    Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months of Step 2 ...

  9. Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

    Known history of human immunodeficiency virus (HIV) infection, hepatitis B, or hepatitis C; testing is not required in the absence of clinical findings or ...

  10. Consumer health - Mayo Clinic

    Take charge of your health. Know your options. Use medicines and supplements wisely. Be informed and ask questions of your health care professionals.